{"meta":{"query_hash":"787a4d9a159c","filters":{"venue":"Hormones and Cancer"},"cohort_total":16,"direct_labels_cover":0,"predictions_cover":16,"exported":16,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/787a4d9a159c","api":"https://metacan.xera.ac/api/v1/cohort?venue=Hormones+and+Cancer"},"results":[{"id":"W1109785384","doi":"10.1007/s12672-015-0233-2","title":"Symptomatic Control of Neuroendocrine Tumours with Everolimus","year":2015,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Thomas Hospital","funders":"","keywords":"Everolimus; Medicine; Neuroendocrine tumors; Carcinoid syndrome; Octreotide; Internal medicine; Gastroenterology; Cohort; Surgery","score_opus":0.02052314898579008,"score_gpt":0.30172888013108096,"score_spread":0.2812057311452909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1109785384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98942703,0.0069069383,0.000035256817,0.0022559133,0.000043475968,0.0003470116,0.000011761084,0.000035907604,0.00093670766],"genre_scores_gemma":[0.99801487,0.00088889746,0.000080138736,0.00032450893,0.00006350477,0.00006232331,0.000001417198,0.000020826013,0.0005435208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904984,0.000025205301,0.00015022283,0.00017351001,0.00034306795,0.00025813736],"domain_scores_gemma":[0.99932396,0.00003624114,0.00006499792,0.00016991825,0.00013858435,0.00026627362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003517713,0.00011821661,0.00030335246,0.00006731648,0.000020624384,0.00000887427,0.000054165383,0.000002608113,0.00002652027],"category_scores_gemma":[0.000048970895,0.00007845081,0.000026859065,0.0001360093,0.00012623116,0.00008640216,0.000025727844,0.00010139682,0.0000033865026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011817866,0.0006272757,0.89836365,0.0013182207,0.00039211905,0.009415127,0.00034373064,0.00041934906,0.026163302,0.00095611875,0.009317575,0.040865693],"study_design_scores_gemma":[0.067006975,0.022793243,0.75103325,0.0011334883,0.0013043538,0.020989155,0.0022383588,0.00543414,0.068757884,0.0010606806,0.05706345,0.0011850271],"about_ca_topic_score_codex":0.0001763508,"about_ca_topic_score_gemma":0.000029814028,"teacher_disagreement_score":0.14733037,"about_ca_system_score_codex":0.000022241236,"about_ca_system_score_gemma":0.00011544384,"threshold_uncertainty_score":0.31991312},"labels":[],"label_agreement":null},{"id":"W1968681830","doi":"10.1007/s12672-014-0209-7","title":"The Relationship Between Bilateral Oophorectomy and Plasma Hormone Levels in Postmenopausal Women","year":2014,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Child Health and Human Development; National Institutes of Health; National Cancer Institute; National Heart, Lung, and Blood Institute; Cancer Care Ontario","keywords":"Oophorectomy; Estrone; Estrone sulfate; Dehydroepiandrosterone sulfate; Medicine; Hysterectomy; Testosterone (patch); Menopause; Sex hormone-binding globulin; Prolactin; Estrogen; Internal medicine; Endocrinology; Hormone; Surgical Menopause; Androgen; Surgery","score_opus":0.03328219526002421,"score_gpt":0.29818345385532374,"score_spread":0.26490125859529956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968681830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928818,0.005543829,0.000006626532,0.00096266164,0.00006287598,0.00018317082,0.000020788488,0.0000192068,0.00031908264],"genre_scores_gemma":[0.99711186,0.001978691,0.00001584555,0.00012380272,0.00020812803,0.000069191105,0.0000043169794,0.00001529424,0.0004728607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992212,0.000031989526,0.00017810888,0.00019012239,0.00011906348,0.00025951557],"domain_scores_gemma":[0.9994346,0.00024890498,0.000045439465,0.00012207069,0.000019987634,0.0001289955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025887127,0.00012041576,0.00021130293,0.00005523874,0.00013972637,0.000042544107,0.00003650209,0.00007227027,0.000012935505],"category_scores_gemma":[0.00004143846,0.00007626455,0.000016171363,0.000121798534,0.00009991823,0.00006280772,0.00003301692,0.00017390515,0.0000024292337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017007977,0.000007827023,0.9313446,0.000013860622,0.000019792858,0.0000017981915,0.0008195564,7.1023095e-7,0.0005213894,0.00023362032,0.00020129976,0.066665426],"study_design_scores_gemma":[0.001314243,0.000317649,0.9805505,0.000025262687,0.00002506097,0.000007970489,0.00016543288,0.00006777244,0.000037370937,0.0006840447,0.01669794,0.000106703286],"about_ca_topic_score_codex":0.0007715151,"about_ca_topic_score_gemma":0.00021281604,"teacher_disagreement_score":0.06655872,"about_ca_system_score_codex":0.00008847646,"about_ca_system_score_gemma":0.000039573857,"threshold_uncertainty_score":0.3109978},"labels":[],"label_agreement":null},{"id":"W1969670583","doi":"10.1007/s12672-010-0049-z","title":"Estrogen Receptor Alpha Phosphorylated at Tyrosine 537 is Associated with Poor Clinical Outcome in Breast Cancer Patients Treated with Tamoxifen","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of Manitoba","funders":"Canadian Institutes of Health Research; Strong; CancerCare Manitoba Foundation","keywords":"Breast cancer; Tissue microarray; Estrogen receptor; Immunohistochemistry; Tamoxifen; Oncology; Internal medicine; Medicine; Estrogen receptor alpha; Cancer; Univariate analysis; Cancer research; Endocrinology; Pathology; Multivariate analysis","score_opus":0.006865548082641771,"score_gpt":0.2604841833744748,"score_spread":0.25361863529183304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969670583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953825,0.0033069637,6.518657e-7,0.000356743,0.00014375108,0.00037569125,0.0003204787,0.000026039292,0.00008720042],"genre_scores_gemma":[0.9951575,0.0029040945,0.000028809318,0.00042629783,0.00011653433,0.00011333365,0.00028371514,0.000060504088,0.0009092393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99840224,0.000056190558,0.00035627084,0.00056817086,0.00019295333,0.00042419147],"domain_scores_gemma":[0.9991682,0.00001623033,0.00020136977,0.00022952413,0.00016605132,0.00021857988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013431828,0.0003296577,0.00038725208,0.000042974734,0.00011513405,0.000029075492,0.0001300625,0.00046139755,0.00012762404],"category_scores_gemma":[0.000014765883,0.00022167986,0.00007997282,0.00022347501,0.0001999493,0.000012211311,0.00007925589,0.00034714342,0.000006879513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017192686,0.0002505995,0.9206401,0.00000874372,0.00030120168,0.000010400879,0.000039222836,0.000004848677,0.070988365,0.0000028335558,0.0021749747,0.0038594042],"study_design_scores_gemma":[0.00666098,0.0011762724,0.92918134,0.00009027706,0.00020230807,0.000019028133,0.000016114664,0.00008958894,0.057322342,0.0000013767168,0.004653712,0.00058667164],"about_ca_topic_score_codex":0.00083921547,"about_ca_topic_score_gemma":0.00059648586,"teacher_disagreement_score":0.013666026,"about_ca_system_score_codex":0.000054856228,"about_ca_system_score_gemma":0.000098217526,"threshold_uncertainty_score":0.90398425},"labels":[],"label_agreement":null},{"id":"W1982550511","doi":"10.1007/s12672-015-0218-1","title":"Androgen Pathway Manipulation and Survival in Patients with Lung Cancer","year":2015,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Cancer registry; Cancer; Proportional hazards model; Oncology; Retrospective cohort study; Epidemiology; Cohort; Population; Prostate cancer; Hazard ratio; Cohort study; Gynecology","score_opus":0.016868394556311034,"score_gpt":0.2968106626372282,"score_spread":0.27994226808091716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982550511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987784,0.010731659,0.000012484296,0.00029501025,0.00007824875,0.0003051391,0.000027683363,0.000011593305,0.0007541275],"genre_scores_gemma":[0.998751,0.00064304564,0.00004549385,0.000093362076,0.000054065433,0.000094191455,0.000030202506,0.000011465402,0.0002771847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99952507,0.000007981299,0.00008247997,0.0001474806,0.00012713765,0.0001098328],"domain_scores_gemma":[0.9997363,0.0000047302874,0.000030334666,0.00006020778,0.00006803825,0.00010038715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003061897,0.000083455234,0.000132868,0.00003689312,0.00003145314,0.000013644169,0.000010602172,0.000030587777,0.000018073242],"category_scores_gemma":[0.0000021483484,0.000056867495,0.00000822194,0.00007885704,0.000022658875,0.00008706473,0.000010650318,0.000037564772,3.4101373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002346485,0.000046052166,0.97439975,0.00002694397,0.00006126103,0.0000041455405,0.0006113497,0.00002463608,0.000010204257,0.00007090198,0.00015729458,0.024352808],"study_design_scores_gemma":[0.0046031275,0.00017501798,0.99242353,0.00007204533,0.00013424884,0.0000012079921,0.00015227735,0.0002570085,0.00003095819,0.00002534767,0.0020398851,0.00008536664],"about_ca_topic_score_codex":0.0018887669,"about_ca_topic_score_gemma":0.000920856,"teacher_disagreement_score":0.024267443,"about_ca_system_score_codex":0.00010999792,"about_ca_system_score_gemma":0.00010202007,"threshold_uncertainty_score":0.2855263},"labels":[],"label_agreement":null},{"id":"W2007488022","doi":"10.1007/s12672-010-0013-y","title":"Circulating Insulin-like Growth Factor (IGF)-I and IGF Binding Protein (IGFBP)-3 Levels and Postmenopausal Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) Cohort","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Growth Hormone and Insulin-like Growth Factors","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; National Institutes of Health; Division of Cancer Prevention, National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Hazard ratio; Breast cancer; Internal medicine; Oncology; Proportional hazards model; Prospective cohort study; Insulin-like growth factor; Risk factor; Cancer; Prostate cancer; Gynecology; Endocrinology; Confidence interval; Growth factor","score_opus":0.015272674043149494,"score_gpt":0.2687764677882709,"score_spread":0.25350379374512144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007488022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850432,0.009461253,0.0000104893,0.0011490416,0.0003448172,0.00310449,0.0007277491,0.000060003018,0.00009890675],"genre_scores_gemma":[0.99150324,0.0063380296,0.00016338745,0.0003163911,0.0005597506,0.0009336006,0.000025972024,0.00007748934,0.000082159095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971252,0.00014234896,0.0006448448,0.00087116763,0.00048587914,0.00073054346],"domain_scores_gemma":[0.99869615,0.0001575905,0.00035133515,0.00025083253,0.00017972259,0.00036435216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063489925,0.0005621549,0.00076704734,0.00024716245,0.00058194145,0.0002568831,0.0001329353,0.0003425857,0.000078407065],"category_scores_gemma":[0.000106060266,0.00040201336,0.000060233222,0.00045743684,0.0003773452,0.00048854953,0.00015468351,0.0010743786,5.964302e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073665967,0.00011155924,0.87891567,0.00026593794,0.0003094122,0.00006269864,0.0039676195,0.0000010645862,0.07807234,0.000083756764,0.00016565049,0.030677712],"study_design_scores_gemma":[0.017363407,0.0005924034,0.97790736,0.00029747453,0.0003691031,0.0001829248,0.00064985,0.0005671924,0.0010896126,0.000063428284,0.00035890457,0.000558316],"about_ca_topic_score_codex":0.01712318,"about_ca_topic_score_gemma":0.0023587884,"teacher_disagreement_score":0.09899174,"about_ca_system_score_codex":0.00010694003,"about_ca_system_score_gemma":0.00031407044,"threshold_uncertainty_score":0.9998432},"labels":[],"label_agreement":null},{"id":"W2018899393","doi":"10.1007/s12672-011-0096-0","title":"Beyond Castration—Defining Future Directions in the Hormonal Treatment of Prostate Cancer","year":2011,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Cancer; Testosterone (patch); Abiraterone acetate; Androgen; Castration; Enzalutamide; Medicine; Intracrine; Abiraterone; Internal medicine; Prostate; Oncology; Androgen deprivation therapy; Cancer research; Hormone; Androgen receptor","score_opus":0.06339424091530371,"score_gpt":0.3743805644422678,"score_spread":0.3109863235269641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018899393","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001184051,0.99488544,9.425956e-8,0.00035437656,0.00019516786,0.0013173935,0.00043297783,0.000011499727,0.0016189729],"genre_scores_gemma":[0.00031479783,0.99502397,0.000019957244,0.000024311812,0.000412004,0.0024076863,0.00016830068,0.000031335632,0.0015976535],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998744,0.00006810511,0.00037082424,0.00032334693,0.00020357891,0.00029015925],"domain_scores_gemma":[0.9994042,0.000047410973,0.00017244395,0.00022218116,0.00007233807,0.00008143971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00009501457,0.00032337336,0.00095087895,0.00016578444,0.00011085359,0.000023229812,0.00007325144,0.00016656976,0.00012858775],"category_scores_gemma":[0.000002249156,0.00016180753,0.00022235332,0.0003881253,0.0001197842,0.0000554518,0.000018310993,0.00021375243,0.000003309748],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001069716,0.00016799134,0.0006963749,0.0019980723,0.00031430382,0.000035627756,0.0022236714,1.2727537e-7,0.0000015345611,0.000188678,0.00044583407,0.9938208],"study_design_scores_gemma":[0.00089435483,0.0005681572,0.0023066066,0.0020176857,0.0011421393,0.00005736529,0.00039385638,0.0000013101086,0.000005709535,0.000030753516,0.9924233,0.00015877733],"about_ca_topic_score_codex":0.0020610096,"about_ca_topic_score_gemma":0.0008134327,"teacher_disagreement_score":0.99366206,"about_ca_system_score_codex":0.00026434296,"about_ca_system_score_gemma":0.0007365608,"threshold_uncertainty_score":0.65983194},"labels":[],"label_agreement":null},{"id":"W2052554512","doi":"10.1007/s12672-010-0008-8","title":"Quantitative Immunohistochemical Analysis and Prognostic Significance of TRPS-1, a New GATA Transcription Factor Family Member, in Breast Cancer","year":2010,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Metastasis and carcinoma case studies","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"Sanofi Pasteur; University of Texas MD Anderson Cancer Center; National Cancer Institute; Sanofi","keywords":"Immunohistochemistry; Breast cancer; Medicine; Oncology; Internal medicine; Progesterone receptor; Prostate cancer; Estrogen receptor; Cancer; Cancer research; Endocrinology","score_opus":0.034546940706006266,"score_gpt":0.31292516034254675,"score_spread":0.27837821963654047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052554512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96005225,0.03859002,0.000082805156,0.0005876604,0.00006925116,0.00028187063,0.00023653566,0.000008347765,0.00009123715],"genre_scores_gemma":[0.9911046,0.0082027465,0.00033938113,0.000068970585,0.000054766748,0.00009638056,0.000010302294,0.000010917465,0.000111905094],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99907005,0.000020730244,0.0002728765,0.00028775423,0.0001745715,0.00017399264],"domain_scores_gemma":[0.99952227,0.00004322782,0.000091662936,0.00013328945,0.00009882952,0.00011072189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000809904,0.000158394,0.000520462,0.00013072074,0.00003845217,0.00001135294,0.000036511112,0.00006586616,0.00016007214],"category_scores_gemma":[0.000015993459,0.000121886806,0.00009349989,0.0003825207,0.000166893,0.000069339694,0.000017223983,0.00017343492,3.0914143e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006022333,0.00006650868,0.18289563,0.00013156654,0.00041132892,0.0000067495157,0.0011654238,9.956347e-7,0.78200096,0.00009226962,0.00024341099,0.032382913],"study_design_scores_gemma":[0.0010887724,0.00011251764,0.99046046,0.00007392748,0.0010085087,0.000008852503,0.0006569061,0.00019422155,0.005779056,0.000024706487,0.00044933005,0.00014272377],"about_ca_topic_score_codex":0.0072683278,"about_ca_topic_score_gemma":0.0020964234,"teacher_disagreement_score":0.80756485,"about_ca_system_score_codex":0.000026828931,"about_ca_system_score_gemma":0.00010864775,"threshold_uncertainty_score":0.9993424},"labels":[],"label_agreement":null},{"id":"W2061481386","doi":"10.1007/s12672-012-0105-y","title":"Differential Role of Estrogen Receptor Beta in Early Versus Metastatic Non-small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Internal medicine; Lung cancer; Oncology; Estrogen receptor; Univariate analysis; Cohort; Immunohistochemistry; Multivariate analysis; Cancer; Stage (stratigraphy); Estrogen; Breast cancer; Pathology; Biology","score_opus":0.013763272116483975,"score_gpt":0.30095409300934683,"score_spread":0.28719082089286285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061481386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518372,0.04647814,0.000016315582,0.00010215984,0.0003493097,0.0003399264,0.00008461751,0.000008358917,0.0007840066],"genre_scores_gemma":[0.9954813,0.0034172884,0.00020911124,0.000025361052,0.00020444907,0.00024538356,0.000021818785,0.000018845498,0.00037643913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993161,0.000012235194,0.0001692742,0.00014082648,0.00011591539,0.0002456643],"domain_scores_gemma":[0.9996346,0.000019947556,0.000071738315,0.000109091656,0.0000385154,0.00012609758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00002621449,0.00012611512,0.0002525963,0.000058782694,0.000033435783,0.000008434034,0.00003456443,0.000038706454,0.00024201967],"category_scores_gemma":[0.0000016140868,0.00009769919,0.00005568935,0.000103621096,0.000030796335,0.00008210665,0.000021538042,0.00007149682,0.0000023686678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001000341,0.00046868486,0.9287653,0.00030716255,0.00068865094,0.0000030425133,0.00643843,0.000015828518,0.027493497,0.00019432738,0.0006429966,0.033981744],"study_design_scores_gemma":[0.013754955,0.0007028748,0.93029344,0.00030858003,0.003520277,0.000002404779,0.0017698228,0.00037678142,0.040739063,0.000018523911,0.008113245,0.00040001812],"about_ca_topic_score_codex":0.005166944,"about_ca_topic_score_gemma":0.00021332127,"teacher_disagreement_score":0.043644138,"about_ca_system_score_codex":0.00010633089,"about_ca_system_score_gemma":0.00011060346,"threshold_uncertainty_score":0.78109086},"labels":[],"label_agreement":null},{"id":"W2086359001","doi":"10.1007/s12672-013-0165-7","title":"Prolactin Receptor Expression and Breast Cancer: Relationships with Tumor Characteristics among Pre- and Post-menopausal Women in a Population-Based Case–Control Study from Poland","year":2013,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"National Cancer Institute; National Institutes of Health; U.S. Department of Health and Human Services","keywords":"Prolactin receptor; Prolactin; Breast cancer; Estrogen receptor; Internal medicine; Carcinogenesis; Endocrinology; Population; Tissue microarray; Medicine; Estrogen receptor alpha; Receptor expression; Receptor; Biology; Cancer; Cancer research; Oncology; Hormone","score_opus":0.0033355770091963903,"score_gpt":0.20980862622993995,"score_spread":0.20647304922074355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086359001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607944,0.0026924403,0.0000052329447,0.00012326421,0.000032246367,0.0007919339,0.00026200374,0.000010208587,0.0000031996624],"genre_scores_gemma":[0.99893636,0.00025315685,0.00003365193,0.000061554594,0.000096865995,0.00050718256,0.0000515109,0.000023546496,0.00003615509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905336,0.000113037284,0.00017674208,0.00034459512,0.000082048486,0.00023023425],"domain_scores_gemma":[0.99952346,0.000033648834,0.00011022676,0.00012314289,0.00005407045,0.00015543833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001146049,0.00018324461,0.00020610697,0.000043230062,0.0001513255,0.000066158085,0.000033244312,0.00011344222,0.00002251842],"category_scores_gemma":[0.00001433598,0.00013453842,0.000008321443,0.000055679975,0.000050560833,0.000023171739,0.000029699058,0.00016488848,3.8314707e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010744238,0.00006547345,0.84689903,0.000017605562,0.000058126312,0.000018099223,0.00041112298,0.000010976404,0.14852658,3.5265217e-7,0.00001353861,0.002904641],"study_design_scores_gemma":[0.0019955598,0.0006191669,0.99562323,0.00006229107,0.000056926863,0.000034547942,0.00048722688,0.0003381366,0.00056377094,0.000003977305,0.000011966109,0.00020321345],"about_ca_topic_score_codex":0.0054462,"about_ca_topic_score_gemma":0.0006824844,"teacher_disagreement_score":0.14872417,"about_ca_system_score_codex":0.000033115106,"about_ca_system_score_gemma":0.000048589864,"threshold_uncertainty_score":0.82330614},"labels":[],"label_agreement":null},{"id":"W2095200029","doi":"10.1007/s12672-013-0149-7","title":"Antiestrogen Use and Survival of Women with Non-small Cell Lung Cancer in Manitoba, Canada","year":2013,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Winnipeg Foundation; Manitoba Medical Service Foundation; Manitoba Health Research Council","keywords":"Antiestrogen; Medicine; Lung cancer; Oncology; Proportional hazards model; Cancer; Internal medicine; Cancer registry; Population; Hazard ratio; Incidence (geometry); Retrospective cohort study; Breast cancer; Estrogen receptor; Environmental health","score_opus":0.004686969256018233,"score_gpt":0.19148655909193726,"score_spread":0.18679958983591904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095200029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832413,0.016317118,0.000005055235,0.000043387357,0.000058326084,0.00022835862,0.000025931262,0.0000021836531,0.00007829748],"genre_scores_gemma":[0.99002415,0.009551701,0.000030240011,0.000054301385,0.00004488269,0.00011404207,0.0000060493326,0.000016650078,0.00015798917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930704,0.00001938475,0.00011612084,0.00020914513,0.000074979194,0.0002733357],"domain_scores_gemma":[0.99966776,0.000008214849,0.000055817643,0.00011018093,0.000050225695,0.00010779327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000042195403,0.00013592604,0.00017179736,0.000021952206,0.000033314915,0.00002084788,0.000054564374,0.00008773609,0.000011487814],"category_scores_gemma":[0.000002197949,0.00010396413,0.000012337484,0.00005988199,0.00005380514,0.00000820424,0.00004808817,0.0000743449,1.17597224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015235406,0.000025290161,0.72809565,0.000115423434,0.00010415969,0.0000089309915,0.00018751454,0.00010630779,0.26697454,0.0000043615214,0.0007287465,0.0034967167],"study_design_scores_gemma":[0.0018634698,0.0004059032,0.87082887,0.00008671978,0.000060794202,0.000008590426,0.0010829135,0.00035775613,0.12297665,0.000004314395,0.0019028374,0.00042118944],"about_ca_topic_score_codex":0.50891024,"about_ca_topic_score_gemma":0.282566,"teacher_disagreement_score":0.22634427,"about_ca_system_score_codex":0.000048928596,"about_ca_system_score_gemma":0.00023254215,"threshold_uncertainty_score":0.7305253},"labels":[],"label_agreement":null},{"id":"W2564769671","doi":"10.1007/s12672-016-0280-3","title":"Thyroid Hormone Controls Breast Cancer Cell Movement via Integrin αV/β3/SRC/FAK/PI3-Kinases","year":2017,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Cell Adhesion Molecules Research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Focal adhesion; Proto-oncogene tyrosine-protein kinase Src; Integrin; Cell biology; Cell migration; PTK2; Cancer research; Actin cytoskeleton; Tyrosine kinase; PI3K/AKT/mTOR pathway; Biology; Kinase; Extracellular matrix; Signal transduction; Cytoskeleton; Cell; Protein kinase A; Biochemistry","score_opus":0.016558099744646948,"score_gpt":0.3062827640482007,"score_spread":0.28972466430355376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564769671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9022342,0.07869705,0.00009636707,0.0063654264,0.00022951618,0.0009345838,0.0002107951,0.000060721926,0.011171321],"genre_scores_gemma":[0.9340613,0.056348402,0.00006129053,0.0011030858,0.0005126321,0.00035192046,0.000013990587,0.000054155535,0.0074932575],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99791235,0.000036304446,0.00032233482,0.0005365913,0.00059705344,0.0005953452],"domain_scores_gemma":[0.9983544,0.000039204348,0.00019423466,0.0007520354,0.00024107844,0.0004190987],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018533596,0.00032049298,0.0005173475,0.00007156753,0.0004121677,0.00016693218,0.00029005882,0.00014034816,0.001287364],"category_scores_gemma":[0.000023675662,0.0002432194,0.0001430345,0.00006865175,0.00024201583,0.00019056331,0.0002852092,0.0003305238,0.000042943084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015386023,0.00029214766,0.014303491,0.00015246854,0.00016562319,0.0001431675,0.00021183972,0.0000055357937,0.745787,0.0000799187,0.019363422,0.21795675],"study_design_scores_gemma":[0.010641927,0.0012106205,0.8315066,0.0003218119,0.00038426206,0.00006691604,0.0007125012,0.0015687087,0.086683035,0.00023364849,0.06584014,0.0008298262],"about_ca_topic_score_codex":0.017299958,"about_ca_topic_score_gemma":0.0013906072,"teacher_disagreement_score":0.8172031,"about_ca_system_score_codex":0.00027072348,"about_ca_system_score_gemma":0.00019271234,"threshold_uncertainty_score":0.9996256},"labels":[],"label_agreement":null},{"id":"W2609422755","doi":"10.1007/s12672-017-0292-7","title":"Growth Hormone Receptor Knockdown Sensitizes Human Melanoma Cells to Chemotherapy by Attenuating Expression of ABC Drug Efflux Pumps","year":2017,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Heritage College","funders":"AMVETS","keywords":"Vemurafenib; Melanoma; Cancer research; Pharmacology; Efflux; Gene knockdown; Drug resistance; ATP-binding cassette transporter; Biology; Medicine; Cell culture; Transporter","score_opus":0.008976481457474645,"score_gpt":0.2622209727446267,"score_spread":0.25324449128715204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2609422755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344534,0.0029661187,0.00008802842,0.0015758852,0.00016433791,0.00035287204,0.000064191554,0.00003438164,0.0013088734],"genre_scores_gemma":[0.9914052,0.0028314095,0.00065485976,0.00023293453,0.00025716453,0.000038054255,0.000022858045,0.000039832717,0.004517692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988461,0.000013918193,0.00027245516,0.00032790535,0.0002685388,0.00027104016],"domain_scores_gemma":[0.999137,0.0000145961,0.00019486804,0.0003570629,0.000107795335,0.00018868413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014850075,0.00021089542,0.00043993557,0.00004877364,0.00037235886,0.00003828152,0.00012859321,0.00009429797,0.00011410559],"category_scores_gemma":[0.0000064368332,0.00016011662,0.00008722435,0.000048111542,0.000098126366,0.00009009929,0.00003457067,0.00011762542,0.0000072500106],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002932585,0.000056437228,0.0026075803,0.000114134666,0.000035547528,0.000005355248,0.00089196395,4.4891826e-7,0.97331035,0.00003570212,0.016280219,0.0063689873],"study_design_scores_gemma":[0.0018538083,0.00019863594,0.028062923,0.00035951225,0.000063304324,0.0000018227996,0.00031016843,0.000009299971,0.96249455,0.00006137785,0.0063632797,0.00022133824],"about_ca_topic_score_codex":0.0005167171,"about_ca_topic_score_gemma":0.000047239268,"teacher_disagreement_score":0.025455343,"about_ca_system_score_codex":0.000029807112,"about_ca_system_score_gemma":0.000027662632,"threshold_uncertainty_score":0.6529366},"labels":[],"label_agreement":null},{"id":"W2783240359","doi":"10.1007/s12672-017-0319-0","title":"The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer","year":2018,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"Institute of Cancer Research; Canadian Institutes of Health Research","keywords":"Ovarian cancer; Glucocorticoid; Medicine; Adjuvant; Tolerability; Glucocorticoid receptor; Chemotherapy; Oncology; Ex vivo; Pharmacology; In vivo; Cancer; Internal medicine; Cancer research; Biology; Adverse effect","score_opus":0.05219477939617357,"score_gpt":0.3815857450098549,"score_spread":0.32939096561368136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2783240359","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008014009,0.9959645,6.052461e-7,0.00043446262,0.0004107055,0.0016773216,0.00018569268,0.000009002356,0.00051630614],"genre_scores_gemma":[0.0013000682,0.99468744,0.00001868739,0.00004672504,0.0003751913,0.0023793601,0.000024345283,0.000045744437,0.0011224219],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836296,0.00005576523,0.0005896388,0.00045893446,0.00020171907,0.0003309884],"domain_scores_gemma":[0.9989444,0.00011772877,0.00034156293,0.00042846447,0.000061634964,0.00010618916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010172542,0.00041433016,0.0016739207,0.00009118995,0.000075955584,0.000029263283,0.000094499286,0.00013750396,0.00015755974],"category_scores_gemma":[0.0000060460493,0.00020727579,0.000304758,0.000239112,0.0001380335,0.000031363965,0.00004580222,0.00012222199,0.00001058511],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006419993,0.00014740958,0.0020664067,0.0023453757,0.00073634076,0.000021873435,0.00013459922,8.117511e-7,0.0000013653246,0.0001102467,0.0004545777,0.9939168],"study_design_scores_gemma":[0.0018605567,0.0004902184,0.0037153736,0.0090163825,0.0024072756,0.000014172118,0.000049447834,0.0000073551478,0.00002859981,0.00001636677,0.9821888,0.00020544667],"about_ca_topic_score_codex":0.007380817,"about_ca_topic_score_gemma":0.0036920975,"teacher_disagreement_score":0.99371135,"about_ca_system_score_codex":0.0005562405,"about_ca_system_score_gemma":0.00084251026,"threshold_uncertainty_score":0.99922913},"labels":[],"label_agreement":null},{"id":"W2809569991","doi":"10.1007/s12672-018-0336-7","title":"Androgen Receptor and Ki67 Expression and Survival Outcomes in Non-small Cell Lung Cancer","year":2018,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Lung cancer; Medicine; Androgen receptor; Internal medicine; Oncology; Hazard ratio; Adenocarcinoma; Estrogen receptor; Cancer; Prostate cancer; Proportional hazards model; Breast cancer; Confidence interval","score_opus":0.012110471826498506,"score_gpt":0.3119544523035704,"score_spread":0.2998439804770719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809569991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9726214,0.024962313,0.000014321848,0.0006903847,0.00019895186,0.0003341772,0.00004650449,0.000013820665,0.0011181377],"genre_scores_gemma":[0.9843021,0.013045285,0.0002166499,0.00023227124,0.00017329324,0.0001554432,0.000008104148,0.000017600467,0.0018492234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993422,0.000011753977,0.00012814037,0.00025323182,0.00008672406,0.00017791986],"domain_scores_gemma":[0.9996758,0.000020427547,0.000042036656,0.00009540765,0.00004418131,0.00012212855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045811725,0.00013539252,0.00024690098,0.00005117671,0.00009311387,0.000023651412,0.000021415153,0.0000629568,0.00011481751],"category_scores_gemma":[0.0000033973017,0.00009503555,0.000019330728,0.00006785171,0.000075014155,0.00007061345,0.000038351118,0.00006241003,0.0000011066184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012585809,0.000057768775,0.9638656,0.00012451799,0.000066642635,0.000005828168,0.0020740926,5.882497e-7,0.012513531,0.000011989447,0.0013217169,0.019831859],"study_design_scores_gemma":[0.005169318,0.00027386824,0.9726741,0.00029955438,0.00031042245,0.0000047008416,0.0007940297,0.00021733891,0.008715709,0.000026821495,0.01127165,0.00024249114],"about_ca_topic_score_codex":0.0022922973,"about_ca_topic_score_gemma":0.0010052405,"teacher_disagreement_score":0.019589368,"about_ca_system_score_codex":0.000056895056,"about_ca_system_score_gemma":0.00006570249,"threshold_uncertainty_score":0.38754374},"labels":[],"label_agreement":null},{"id":"W2904923544","doi":"10.1007/s12672-018-0353-6","title":"A Targeted Bivalent Androgen Receptor Binding Compound for Prostate Cancer Therapy","year":2018,"lang":"en","type":"article","venue":"Hormones and Cancer","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"National Research Council Canada; McGill University; Montreal Neurological Institute and Hospital; Jewish General Hospital","funders":"Prostate Cancer Canada; Jewish General Hospital; Movember Foundation","keywords":"Bivalent (engine); Prostate cancer; Androgen receptor; Prostate; Oncology; Computational biology; Medicine; Internal medicine; Biology; Cancer; Chemistry","score_opus":0.04501632806562778,"score_gpt":0.349986072406982,"score_spread":0.3049697443413542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904923544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9241698,0.07076379,0.0000120630775,0.002946113,0.00029087852,0.0012232669,0.00031883531,0.00004501079,0.00023024698],"genre_scores_gemma":[0.86789995,0.119992085,0.0002780063,0.00046662323,0.0009903171,0.0014458665,0.00011856056,0.000052722222,0.008755887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989685,0.000014470403,0.00015001364,0.00030458078,0.00018152657,0.00038089883],"domain_scores_gemma":[0.9994317,0.000022153206,0.00005424278,0.00013015067,0.00019978636,0.0001619602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010096934,0.00016400014,0.00024940277,0.000078371624,0.00023572834,0.000040502706,0.000049390906,0.00006285117,0.00040987734],"category_scores_gemma":[0.0000047740527,0.00010935202,0.00006520259,0.00017137206,0.00017747359,0.00007192413,0.000025471576,0.00007597608,0.000012339338],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009908177,0.00025666994,0.10515403,0.00034165455,0.0009113828,0.000017214757,0.003357832,0.0000010056822,0.34067747,0.000057137444,0.06392367,0.47539374],"study_design_scores_gemma":[0.010587797,0.0023413831,0.016820082,0.00028586085,0.00012675016,0.000011499273,0.00044983826,0.00028369515,0.18695058,0.000091541326,0.7816912,0.0003597614],"about_ca_topic_score_codex":0.00042822273,"about_ca_topic_score_gemma":0.00006507708,"teacher_disagreement_score":0.71776754,"about_ca_system_score_codex":0.00013493336,"about_ca_system_score_gemma":0.00019039324,"threshold_uncertainty_score":0.44878694},"labels":[],"label_agreement":null},{"id":"W3016993085","doi":"10.1007/s12672-020-00385-3","title":"Advanced Adrenocortical Carcinoma (ACC): a Review with Focus on Second-Line Therapies","year":2020,"lang":"en","type":"review","venue":"Hormones and Cancer","topic":"Adrenal and Paraganglionic Tumors","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Adrenocortical carcinoma; Clinical trial; Capecitabine; Mitotane; Oncology; Internal medicine; Systemic therapy; Intensive care medicine; Malignancy; Cancer","score_opus":0.03410025276196027,"score_gpt":0.32795962104639287,"score_spread":0.2938593682844326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016993085","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015291233,0.9961291,0.000005906876,0.0013284045,0.000064892425,0.0011958132,0.00008651106,0.000046615045,0.0009898241],"genre_scores_gemma":[0.0005878962,0.9958769,0.000049051006,0.0013718442,0.00043084405,0.0004709843,0.0000538288,0.00006842213,0.0010902236],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984988,0.000047578746,0.00042896334,0.000501939,0.00024120865,0.00028148704],"domain_scores_gemma":[0.9991301,0.00005987329,0.00020935081,0.00028324145,0.00005482224,0.00026262525],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0000557853,0.0004837619,0.0021289652,0.000055312106,0.000059406597,0.000014114212,0.000094419,0.00012516479,0.0007412979],"category_scores_gemma":[0.000013658904,0.00026125475,0.00027301407,0.00028834437,0.00008943172,0.00003529737,0.00003954168,0.0004777126,0.0000395558],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021193863,0.00003048602,0.0000067278693,0.027822992,0.00020403111,0.0010555029,0.000036166737,4.265381e-8,2.1508973e-7,0.00014027876,0.001359674,0.96913195],"study_design_scores_gemma":[0.00067895226,0.001122692,0.00013785795,0.049192034,0.0020756514,0.0013930446,0.000013521559,0.0000015010224,0.0000032316766,0.000019306106,0.9450283,0.0003338917],"about_ca_topic_score_codex":0.000021340002,"about_ca_topic_score_gemma":0.000028527753,"teacher_disagreement_score":0.96879804,"about_ca_system_score_codex":0.00006123105,"about_ca_system_score_gemma":0.00034830355,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null}]}